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1. ABSTRACT 
 
Syndecans are cell surface heparan sulfate proteoglycans which are present in all tissues and 
cell types and have distinct temporal and spatial expression patterns. They play important roles in 
embryonic development of the organism and control relocation and alteration of extracellular matrix 
components. Syndecans regulate cell migration, adhesion and proliferation and are engaged in 
tissue injury, inflammation processes, pathogenesis of infectious diseases and tumor biology. 
This thesis summarizes the results of studies on one of the syndecan family receptors – 
syndecan-3 (also known as N-syndecan). This proteoglycan is abundantly expressed in developing 
brain. Syndecan-3 acts as a signaling receptor upon binding of its ligand, heparin-binding growth 
associated molecule (HB-GAM; also known as pleiotrophin), which activates the cortactin – c-Src 
signaling pathway. This leads to rapid neurite extension in neuronal cells, which makes syndecan-3 
an interesting transmembrane receptor in neuronal development and regeneration. However, little is 
known about the signaling mechanism of syndecan-3. Here I show formation of ligand-syndecan-3 
signaling complexes at the cell surface using fluorescence resonance energy transfer (FRET) and 
bioluminescence resonance energy transfer (BRET). Ligand binding leads to dimerization of 
syndecan-3 at the cell surface. The dimerized syndecan-3 colocalizes with actin in the filopodia of 
cells. Lysine 383 in the juxtamembrane (ERKE) sequence and G392 and G396 from GXXXG 
canonical motif are shown to be important for the ligand-induced dimerization, whereas the 
cytosolic domain is not required for the dimerization. 
In addition to acting as a signaling receptor, syndecan-3 acts as a co-receptor in epidermal 
growth factor receptor (EGFR) ligand binding. FRET analysis suggests that interactions of 
syndecan-3 and EGFR depend on a shared ligand such as heparin-binding EGF-like growth factor 
(HB-EGF). Furthermore, it was shown that syndecan-3 may act as a receptor for other ligands, like 
glial cell line-derived neurotrophic factor (GDNF). 
In addition, I have found a new receptor for HB-GAM – glypican-2 – which may be 
involved in regulation of HB-GAM signaling by competing with syndecan-3 for ligand binding. 
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2.  REVIEW OF LITERATURE 
2.1.  Proteoglycans 
Proteoglycans (PGs) are macromolecules containing one or more glycosaminoglycan 
(GAG) chains covalently linked to a core protein. PGs are present in all cells and tissues as 
components of the extracellular matrix (ECM) (Oldberg et al, 1990; Iozzo and Murdoch, 1996; 
Kresse and Schönherr, 2001), as membrane-linked receptors (Couchman, 2010) or in intracellular 
location in secretory granules (Varki et al, 2009). PGs may be classified based on their protein 
sequence similarity, GAG composition, their localization or functional properties. 
Table 1. Proteoglycans are structurally a very diverse group of molecules. 
* Abbreviations used in this table: GPI - GPI anchor; Type I - Type I membrane proteins; ECM - 
extracellular matrix; HS - heparan sulfate; CS - chondroitin sulfate; KS - keratan sulfate;  DS - 
dermatan sulfate; NG2 - neural/glial antigen 2 
 
Core protein size ranges widely from 17 kDa for serglycin (Toyama-Sorimachi et al, 1995) 
up to 400 kDa for perlecan (Noonan et al, 1991) (Table 1). PGs differ not only by amino acid 
sequences but also by glycan backbone. They may contain four different types of GAG chains: 
heparan sulfate (HS), chondroitin sulfate (CS), keratan sulfate (KS) and dermatan sulfate (DS) 
(Table 1; Fig. 1). In the core protein of PGs almost all HS and CS chains are linked to serine 
residues in the Ser-Gly-X-Gly sequence (Kjellen and Lindahl, 1991). There are few exceptions in 
attachment site sequences, like in the versican recognition sequence Ser-Gly-Glu/Asp-X. In some 
cases the Ser-Gly dipeptide may be flanked by acidic and hydrophobic amino acid residues 
(aggrecan). In contrast to heparan/chondroitin GAG, KS is linked to another recognition sequence. 
There are two types of KS which differ by the protein core linker. KS class I is linked to asparagine 
in the Asn-X-Ser/Thr consensus sequence while KS class II is linked to serine/threonine residues 
of Asn-X-Ser/Thr.  
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The number and composition of GAG chains varies from one in the case for decorin (Mann 
et al, 1990) to more than 100 for aggrecan (Chandrasekaran and Tanzer, 1992). For many PGs 
the site of GAG chain attachment can be easily predicted based on their amino acid sequence. Most 
GAG chains bind to serine residues of the core proteins. GAG chain synthesis is initiated by 
xylosylation of the serine residues by xylosyltransferase.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Disaccharide structures of glycosaminoglycans. Glycosaminoglycans consist of 
repeating disaccharide units. Chondroitin sulfate (CS), dermatan sulfate (DS), heparan 
sulfate (HS), keratan sulfate (KS). Sulfation of sugar and acid residues shown by grey (4S; 
6S; 2S; NS). 
 
In addition to GAG anchoring sequences PGs may contain many other domains: 
complement regulatory protein (CRP) like domain, hyaluronic acid (HA) like domain, lectin-like 
domain, EGF-like domain, Ig domain and non-GAG regions for anchoring to the cell membrane 
through transmembrane domain or by glycophosphatidylinositol (GPI) anchor (Iozzo, 2000). 
Proteoglycans play important roles in many cellular processes (Bernfield et al, 1999), like 
regulation of cell migration (Moon et al, 2005) and adhesion (Woods et al, 1998), and mechanical 
support of tissues (Cavalcante et al, 2005). They are involved in regulation of embryonic 
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development (Cui et al, 2013; Lin, 2004) and in development of synaptic structures (Okamoto et 
al, 2001; Reizes et al, 2008; de Wit et al, 2013). PGs are engaged in coagulation and complement 
cascade regulation (Clark et al, 2013) and in virus binding (Bacsa et al, 2011; Secchiero et al, 
1997).  PGs regulate activity of many enzymes by anchoring them to the cell surface and by acting 
as intracellular storage sites of enzymes in inactive form. Various growth factors (Hardingham 
and Fosang, 1992) and many components of the ECM are regulated by different PGs (Schaefer, 
2010; Heinegård, 2009; Kjellén and Lindahl, 1991). 
  
 
 
 
 
 
 
 
 
 
Figure 2. The structure of syndecan family receptors. Schematic structure of four 
members of syndecan family receptors. Transmembrane, intracellular (C-terminal) and 
extracellular (N-terminal) domains are show in black, grey and brown respectively. GAG 
chains are indicated by wave lines. The N-terminal GAG cluster contains both HS and CS 
chains while the C-terminal cluster may have only CS chains or can be free of any GAG 
chains. The secondary names are given in brackets. Molecular mass calculated for the 
protein core is indicated below the schematic structures. 
 
2.2. Syndecan family of proteoglycan receptors  
The syndecan protein family consists of four type I transmembrane proteins: Syndecan-1 
(CD138), Syndecan-2 (fibroglycan), Syndecan-3 (N-syndecan) and Syndecan-4 
(Amphiglycan, Ryudocan) (Fig. 2).  
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Syndecan-1 is the first form of the protein family that was initially found in murine 
epithelial cells. Syndecan-1 from simple epithelia has a larger molecular size (160 kDa) than the 
proteoglycan from stratified epithelia (92 kDa) (Sanderson and Bernfield, 1988). It has been 
shown that the protein cores are identical but HS and CS chains differ in number and size. Such 
kind of polymorphism correlates with difference in epithelial cell organization. Syndecan-1 in 
stratified epithelia surrounds the entire cell while the proteoglycan from simple epithelia is localized 
mainly on the basolateral membrane (Sanderson and Bernfield, 1988).  The calculated molecular 
mass of the protein core is 33 kDa which is much smaller than 69 kDa given by SDS-PAGE (SDS-
resistant dimers) (Miettinen and Jalkanen, 1994). 
Syndecan-2 (fibroglycan) (23 kDa) was cloned from human lung fibroblasts (Marynen et 
al, 1989) and from rat liver (Pierce et al, 1992) as a heparan sulfate proteoglycan (HSPG) with core 
proteins 48-/90- kDa observed on SDS-PAGE. Deglycosylated fibroglycan is recognized in 
immunoblotting by antiserum to the ectodomain of syndecan-1 (Marynen et al, 1989). 
The third member of the syndecan family, N-syndecan (neural syndecan, syndecan-3) has 
the core protein of 44 kDa. It was isolated by screening an embryonic chicken limb bud cDNA 
library (Gould et al, 1992) and neonatal rat Schwann cell cDNA library (Carey et al, 1992) with 
murine syndecan-1 cDNA probe. Syndecan-3 has a mucin-like domain (threonine, serine and 
proline rich regions), a unique motif for syndecan family. 
The last member of the syndecan family, syndecan-4 (amphiglycan) was isolated from 
human lung fibroblasts using an oligonucleotide primer conserved in the cytoplasmic domain of 
syndecan-2 and -3 (David et al, 1992). It was PCR-amplified and finally after screening a cDNA 
fibroblast library one cDNA clone (35K17) encoding the full-length protein with 198 amino acids 
was isolated. The proteoglycan migrates in SDS-PAGE after heparitinase and chondroitinase 
treatment as a single band with size around 35 kDa. The predicted molecular mass is 21.6 kDa. 
Another group cloned independently syndecan-4 (ryudocan) from a cell (RFP-EC) line from rat pad 
endothelia (Kojima et al, 1992). 
 
 
 
 
13 
 
2.3. Syndecan core proteins 
Syndecans are type I transmembrane proteins with a similar structure that contains the N-
terminal extracellular domain with a few sequences for HS and CS attachment, a single 
transmembrane domain and a short C-terminal cytoplasmic domain. The protein core sizes vary 
from 21 to 44kDa. Syndecans have a highly conserved sequence in the transmembrane and 
cytoplasmic domains in contrast to the extracellular domains which have low homology within the 
syndecan family (Fig. 3). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  The phylogenetic tree of syndecan family (Chen et al, 2002). 
 
2.3.1. Extracellular domain 
The extracellular domains of all syndecans have low homology with each other, with the 
exception of short sequences for GAG attachments. GAG chains are involved in interactions with 
ECM proteins and in binding of different ligands. All four syndecans contain HS chains but only 
syndecan-1, -3 and -4 have also CS chains in separated clusters near the membrane. The total 
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number of GAG attachment sites varies from four to seven. GAG chain synthesis is initiated by 
transfer of xylose by xylosyltransferase to specific residues. Almost all HS and CS chains in PGs 
are linked to serine residues in Ser-Gly attachment sites in the core protein. Typically this dipeptide 
is flanked by acidic residues (Esko and Zhang, 1996). Mutation of such acidic residues in flanking 
region leads to substitution of HS with CS chains (Zhang et al, 1995). This shows that flanking by 
acidic residues is necessary but not sufficient for assembling HS chains on PGs, and sequences 
surrounding the attachment sites may regulate GAG composition. The expression level of the core 
protein can affect GAG composition as well. Overexpression of syndecans leads to a low proportion 
of GAGs in the proteoglycan.  Different tissues and cells vary in syndecan composition (Kato et al, 
1995). Syndecan-1 has two clusters of Ser-Gly attachment sites. Three sites are located near its N-
terminal end and two sites on the C-terminal part of the ectodomain close to the transmembrane 
region. The N-terminal sites (DGSGD and FSGSGTG) may have both HS and CS chains while the 
GAG attachment sites (EGSGE and ETSGE) in the C-terminal cluster may have only CS chains or 
can be free of any GAG chains (Kokenyesi and Bernfield, 1994). Two GAG attachment domains 
of syndecan-3 are separated by approximately 200 amino acids sequence (Thr-Ser-Pro-rich region) 
that displays homology to mucin-like proteins (Carey et al, 1997). 
The last four amino acids (ERKE) in the juxtamembrane region of syndecan-3 play a key 
role in functional oligomerization (Choi et al, 2005). Gel permeation chromatography and cross-
linking analysis of N-syndecan fusion proteins revealed that the lysine residue is essential for 
complex formation. Other syndecans have a similar motif in their structure - DRKE, KRTE and 
ERTE - for syndecan-1, -2 and -4 respectively. Deletion of these motifs from syndecan-2 or -4 does 
not decrease SDS-resistant dimer formation (Choi et al, 2005). For syndecan-1, functional roles of 
the DRKE sequence is not yet clear (Zong et al, 2011). 
2.3.2. Transmembrane domain 
The transmembrane domain of all syndecans has highly conserved sequences. They all 
contain a GXXXG motif which plays a crucial role in functional oligomerization and may form 
SDS-resistant dimers (Asundi and Carey, 1995). In syndecans -2, -3 and -4 the transmembrane 
domains are sufficient for inducing dimerization (Choi et al, 2005). 
2.3.3. Cytoplasmic domain 
The cytoplasmic domain is the most conserved sequence of syndecans (Fig. 4). It consists of 
two conserved regions (C1 and C2) which are present in all four syndecans and a central variable 
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(V) region that is unique to each syndecan family member (Couchman, 2003; Beauvais and 
Rapraeger, 2004). Oligomerization status of cytoplasmic domain correlates with binding of the 
protein kinase Cα (PKCα) and its activation (Oh et al, 1997a, b). 
Figure 4. Sequence alignment of syndecan cytoplasmic domains. The cytoplasmic 
domain consists of membrane proximal conserved region (C1), variable region (V) and membrane 
distal conserved region (C2). Potentially phosphorylated sites of tyrosine residues (pink) and serine 
residues (green) are shown. Abbreviations: Sdc1, Sdc2, Sdc3 and Sdc4 are syndecan -1 to -4 
respectively. 
 
The C1 (membrane proximal) region is the most unstructured region in syndecan dimers 
(Shin et al, 2001). It contains positively charged amino acids and is responsible for linkage to the 
actin cytoskeleton. It has been shown that syndecan-2 interacts in C1 region with one of the ERM 
family proteins, an F-actin binding ezrin by it FERM domain (Granés et al, 2000). In addition, the 
C1 region interacts with protein tyrosine kinase (c-Src) and their substrate cortactin (Kinnunen et 
al, 1998). 
The V region is mainly responsible for oligomerization status of the syndecan cytoplasmic 
domain. Nuclear magnetic resonance (NMR) studies of synthetic peptides from syndecan-4 show 
that two parallel strands twist twice in the variable region and form a symmetric dimer (Shin et al, 
2001). Phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) binds the V region which stabilizes 
the structure and leads to activation of  the PKCα (Horowitz et al, 1999; Yoneda and Couchman, 
2003). In addition, the variable region of syndecan interacts with α-actinin (Greene et al, 2003; 
Choi et al, 2008) and syndesmos (Denhez et al, 2002). Syndecan-4, through syndesmos, activates 
paxillin and focal adhesion kinase (FAK) and suppresses small Rho-family GTPases, which results 
in focal adhesion turnover (Ren et al, 2002; Bass and Humphries, 2002). 
The C2 (membrane distal) region consists of four amino acids (EFYA) which are identical 
in all syndecans. This region interacts with proteins containing a PDZ domain. The yeast two-
hybrid system revealed new interacting proteins for the C2 region of syndecans: syntenin (mda-9) 
(Grootjans et al, 1997; Zimmermann et al, 2001), Calcium/calmodulin-dependent serine protein 
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kinase (CASK) (Cohen et al, 1998; Hsueh et al, 1998), synectin (Gao et al, 2000) and synbindin 
(Ethell et al, 2000). Syntenin, CASK and synectin are involved in formation of the cytoskeleton 
scaffold. In contrast to other PDZ-domain proteins, synbindin has an atypical PDZ domain and is 
probably involved in vesicular transport and membrane trafficking in dendrites (Ethell et al, 2000). 
There are two tyrosine residues in the syndecan cytoplasmic domains which can be 
phosphorylated: one residue is close to the C1 – V boundary, the other in the V region. 
Phosphorylation of these tyrosine residues by EphB2 receptor tyrosine kinase is a crucial event for 
formation EphB2-syndecan-2 complex and for dendritic spine formation in hippocampal neurons 
(Ethell et al, 2001). In addition, there are a few serine residues which may be also involved in 
regulation of different interactions by their phosphorylation (Fig. 4). Phosphorylation of serine from 
C1 region of the syndecan-2 cytoplasmic domain by the PKCδ leads to decreased affinity of V 
region for PIP2 and for downregulation in PKCα activation (Horowitz and Simons, 1998 a, b). 
2.3.4. Soluble syndecans 
Syndecans are mainly present on the plasma membrane of the cells. In addition to regulation 
of syndecan levels by transcription, translation or exocytosis via the protein kinase A (PKA) 
(Hayashida et al, 2006), shedding of the ectodomain plays a major role in control of syndecan 
distribution. Many enzymes may cleave the syndecan protein core at more than one site in the N-
terminal part, but the main cleavage sites are localized in the juxtamembrane region. The main 
enzymes which regulate syndecan protein core shedding are plasmin (Schmidt et al, 2005), 
thrombin (Subramanian et al, 1999) and matrix metalloproteinases (MMP) -2, -3, -7, -9 (Choi et 
al, 2012; Manon-Jensen et al, 2013). Shedding is highly regulated by chemokines (Hayashida et 
al, 2009), interleukins (Kwon et al, 2014), growth factors (Subramanian et al, 1999) or by loss of 
HS chains (Ramani et al, 2012). The ectodomain shedding is involved in host defense mechanisms 
(Park et al, 2004), in inflammation (Rops et al, 2004) and in regulation of response to some 
growth factors.  
 
2.4.Glycosaminoglycan chains of syndecans 
Although the ectodomain of syndecans may participate in protein-protein interactions 
(Whiteford and Couchman, 2006), the main role in communication of syndecans with ligands and 
ECM occurs through HS and CS GAG chains. Many studies have shown that heparinase treatment 
or inhibition of HS chain synthesis by xylosides (Schwartz et al, 1974) leads to loss of syndecan 
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functions (Sasisekharan et al, 1994; Chu et al, 2004). GAGs are linked to extracellular domains 
having short and conserved recognition sequences for polysaccharide attachment to serine residues 
(Esko JD and Zhang L, 1996). The number of GAG chains and their length may differ in various 
tissues. It may be regulated by serine phosphorylation, by the concentration of UPD-xylose or by 
the expression level of xylosyltransferase. 
2.4.1. Heparan sulfates 
All syndecans have HS chains. The predicted number of HS GAG attachment sites in 
syndecan protein core varies from three for syndecan-1 (Langford et al, 1998; Ramani et al, 2012) 
up to six for syndecan-3 (Elenius and Jalkanen, 1994). 
The initial step of glycosylation is transfer of xylose by xylosyltransferase to serine residue 
in the protein (Fig. 5). Sequential transfer of two galactose residues by β1–4 and β1–3 
galactosyltransferases and one glucuronic acid by β1–3 glucuronosyltransferase is similar during 
HS and CS biosynthesis. After this step their biosynthesis pathways differ from each other.  
  
 
 
 
 
 
 
Figure 5. The biosynthesis of sulfated glycosaminoglycans. Glycosylation starts from 
transfer of xylose by xylosyltransferase (XylT) to specific serine residues in the Ser-Gly-X-
Gly sequence followed by chain expanding with galactosyltransferases I and II (GalT-I and 
-II) and glucuronyltransferase I (GlcAT-I). After this step HS and CS biosynthesis 
pathways differ from each other. HS biosynthesis enzymes: exostosin-like 
glycosyltransferase-2 (EXTL2) and exostosin glycosyltransferase-1 and -2 (EXT1 and -2). 
CS biosynthesis enzymes: N-acetylgalactosaminyltransferases I and II (GalNAcT-I and -
II), and glucuronosyltransferase (GlcAT-II). From Sugahara and Kitagawa, 2000 (with 
permission from Elsevier B.V.). 
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Addition of N-acetylglucosamine is catalyzed by EXTL2 (exostosin-like glycosyltransferase 
2) and probably by EXTL3 (genecards.org). The next step consecutively controlled by two EXT1 
and EXT2 (exostosin glycosyltransferase-1 and -2) enzymes leads to polymerization with GlcNAc 
and GlcA residues. The last steps are modifications of glucuronic acid residues and N-
acetylglucosamine by epimerase and by sulfotransferases (N-, 2-O-, 6-O- and 3-O-), enzymes with 
3′-phosphoadenyl-5′-phosphosulfate (PAPS) as a sulfo group donor.  Glucuronic acid is converted 
to Iduronic acid (IdoA) by epimerase (Varki et al, 2009). 
2.4.2. Chondroitin sulfates 
Syndecans may also contain CS chains close to their transmembrane part. They occur in 
syndecan-1 (Ueno et al, 2001), -3 (Gould et al, 1992) and -4 (Deepa et al, 2014). The number of 
CS GAG attachment sites in syndecan protein core can be up to two. 
After the initial synthesis of the polysaccharide linker, N-acetylgalactosamine is transferred 
by the GalNAcT-I (N-acetylgalactosaminyltransferase) enzyme (Fig. 5). The next steps are similar 
to HS biosynthesis – polymerization of glucuronic acids and N-acetylgalactosamine by   GalNAcT-
II (N-acetylgalactosaminyltransferase) and GlcAT-II (glucuronosyltransferase). GlcA is converted 
to IdoA by epimerase, and GalNAc residues are sulfated by 4-O-, 6-O- and 2-O-sulfotransferases 
and PAPS. 
It is believed that posttranslational modifications may play an important role in syndecan 
functions. For instance 6-O-sulfation (Lopes et al, 2006) and to a lower degree 2-O-sulfation 
(Sugaya et al, 2008) are responsible for the formation of the FGF2-binding site while 3-O-sulfation 
is needed (Hirano et al, 2012) for the antithrombin binding site. 
 
2.5. Expression profiles of syndecans 
2.5.1. Tissue specific expression  
Syndecan-1 is expressed in epithelia and mesenchymal tissues (Saunders et al, 1989), 
syndecan-2 mainly in mesenchymal tissues, syndecan-3 predominantly in neuronal and skeletal 
tissues, and syndecan-4 is found in many cells and tissues. Syndecan expression profiles are tightly 
regulated by many growth factors (Shimo et al, 2004), ligands (Cizmeci-Smith et al, 1997; Dobra 
et al, 2003; Koyama et al, 1995; Vainio et al, 1989) and transcription factors (Wong et al, 1998). 
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2.5.2. Expression profile during development 
Cell surface PGs play important roles in embryonic development of the organism. They 
control relocation and alteration of ECM components, cellular adhesion and cell proliferation. All 
four syndecans have temporal and spatial expression patterns that are strictly regulated during 
embryogenesis. Each mammalian cell and tissue expresses at least one syndecan (Tkachenko et al, 
2005). 
Syndecan-1 is expressed during embryogenesis in the condensing mesenchyme surrounding 
the limb bud and in early tooth development of rat embryo (E11-E17). Mesenchymal (precartilage) 
condensation is also mediated by many other ECM and cell adhesion molecules including 
syndecan-3 (Hall and Miyake, 2000). Expression of syndecan-1 and epithelial-mesenchymal tissue 
interactions regulate each other (Vainio et al, 1989). It has been shown that in developing lung 
mesenchyme syndecan-1 and -2 have coordinated expression (Bernfield et al, 1992). Differential 
expression of syndecan-1 and -2 also occurs in other tissues. Syndecan-2 is expressed in the 
mesenchymal cells and the basement membrane interface of kidney, stomach and pancreas, while 
syndecan-1 shows an epithelial cell surface localization (David et al, 1993). 
Immunohistochemistry and in situ hybridization show that syndecan-2 expression is weak at 
the early stage of mouse embryo development (David et al, 1993). At the stage E11 syndecan-2 in 
mesenchyme of the early limb bud has weak staining which is changed and increased at E17. In the 
process of lung development syndecan-2 expression is enhanced from weak expression at E12 to a 
high level at E13-17. At stage E17, syndecan-2 shows a strong staining in perichondrial and 
periosteal tissues and in the intervertebral ﬁssurae and a less intense staining in vertebral bodies. 
Spinal cord displays negative staining. During mouse embryogenesis syndecan-2 is expressed 
exclusively in mesenchymal cells. No syndecan-2 is found in epithelial cells at any stage of 
development (David et al, 1993). 
Syndecan-1 and -3 transcripts always show complementary (mutually exclusive) expression 
profiles (Carey et al, 1992). Syndecan-3 is expressed in early condensations of limb cartilages of 
the chicken embryo (Koyama et al, 1995). This PG is involved in the first steps of skeletogenesis. 
Perichondrium surrounding bones is rich in syndecan-3 transcripts, and during bone elongation the 
expression becomes more pronounced. Syndecan-3 transcripts may be found from the chicken stage 
17 (corresponding to mouse E2.5) in limb bud and the expression stays constant until the stage 28 
(E6). Syndecan-3 at the stages 25–36 (E4.5–E10) is expressed in mesenchymal cells around femur, 
quite abundantly around ulna and much less around humerus (mainly in distal part). Syndecan-3 is 
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expressed in the elbow joint region (articular cap), in metacarpal and carpal regions, and in 
phalanges and calvaria (at E14). Northern blot analysis shows that syndecan-3 has a constant level 
of transcripts at the stages 43–45 (E17–E20) in chicken wing buds during development (Koyama et 
al, 1995). Syndecan-3 starts to be expressed in neural tube at day 5 of chicken embryonic 
development in the floor plate of the neural tube, and at day 20 it is widespread in cortex and 
cerebellum. By in situ hybridization and immunohistochemistry it was shown that syndecan-3 
displays high expression during the whole period of embryonic development in many  tissues 
starting from optic vesicles (E1.5–2), branchial arches (E2), lens (E5) and genital ridge (E7) (Gould 
et al, 1995). In addition, some temporal dermal expression of syndecan-3 may be involved 
in feather development (Song et al, 2004). 
Syndecan-4 is expressed during development of Xenopus embryos in neural tube on the 
region of its closure, and regulates neural crest-directed migration (Matthews et al, 2006). It is also 
involved in control of gastrulation (Munoz et al, 2006). Studies on the syndecan-4-/- knockout 
mice have shown that syndecan-4 plays an important role in skeletal muscle development and 
regeneration (Cornelison et al, 2004). 
 
2.6. Syndecans and disease 
Syndecans play an essential role in tissue injury (Edwards and Hammarlund, 2014), 
inflammation processes (Götte, 2003b), pathogenesis of infectious diseases and tumor biology 
(Teng et al, 2012). Many molecules (cytokines, proteinases, growth factors) which interact with 
syndecans are involved in inflammatory responses (Alexopoulou et al, 2013). Shedding of the 
syndecan ectodomain can control distribution and activity of all these interacting molecules. In turn, 
chemokines (Hayashida et al, 2009), thrombin (Subramanian et al, 1999), growth factors 
(Subramanian et al, 1999), MMP-2,-9 (Manon-Jensen et al, 2013) and MMP-7 (Choi et al, 2012) 
or loss of HS chains (Ramani et al, 2012) highly regulate syndecan shedding. 
Syndecans mediate initial steps of infections, such as attachment and entry of pathogens 
(HIV-1 and human papilloma virus) to cells (Gallay, 2004; de Witte et al, 2007 a,b). They may 
also be involved in inhibition of host defense mechanisms by induction of their ectodomain 
shedding (Park et al, 2004). 
Syndecans are also involved in some processes during human chronic cholestatic liver 
disease, such as ductular reaction and fibrogenesis. Overexpression of syndecan-1 in bile duct 
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epithelial cells and syndecan-3 in Ito and Kupffer cells leads to the deposition of ECM components 
(Roskams et al, 1996). 
2.6.1. Syndecans in inflammation 
Syndecan -1, -2 and -4 are involved in regulation of all steps of leukocyte homing. 
Syndecans regulate leukocyte rolling. Syndecan-1 null (Sdc1
-/-
) and syndecan-4 null (Sdc4
-/-
) mice 
showed a dramatic loss in leukocyte adhesion to the vessel wall (Götte et al, 2002). Such changes 
in leukocyte-endothelial cell interactions may result in uncontrolled inflammatory response and lead 
to autoimmune diseases, asthma, and atherosclerosis (Muller, 2002). Interestingly, syndecan-3 null 
(Sdc3
-/-
) mice display increased rolling and adhesion (Kehoe et al, 20014). Transendothelial and 
transepithelial stages of leukocyte migration are regulated by syndecans through E-cadherin 
inhibition (Contreras et al, 2001) and by generation of chemokine gradient (Götte and 
Echtermeyer, 2003a) respectively.  
Although the main role in permeability of the glomerular filter is played by perlecan, agrin, 
and collagen XVIII, the syndecans are also involved in regulation of kidney inflammation. At the 
inflammation stage, glomerular syndecans-1 and -4 display increased expression level and are in 
general shed from the cell surface (Rops et al, 2004). 
2.6.2. Syndecans in malignant transformation 
Syndecans play important roles in tumor cell invasion (Subramanian et al, 1997), 
metastasis (Diamantopoulou et al, 2012) and cell adhesion. The extracellular domains of 
syndecans are mainly responsible for such processes due their functions as receptors or “co-
receptors” for some other receptors. 
Any changes in syndecan expression (overexpression as well as loss of expression) may 
have a big influence on tumor cell invasion. It has been shown that loss of syndecan-1 expression 
reduces cell survival level in head and neck squamous cell carcinomas (Anttonen et al, 1999). On 
the contrary, overexpression of syndecan-1 may activate metastasis and tumorigenesis (Alexander 
et al, 2000). Effect of overexpression of syndecan-2 was shown in colon cancer cells where this 
proteoglycan regulates cell proliferation and cell invasion and migration through control of matrix 
metalloproteinases (Contreras et al, 2001; Park et al, 2002; Wei et al, 2014). Overexpression of 
syndecan-4 is a hallmark of tumor cell proliferation (Yung et al, 2001). 
22 
 
Experiments with RPTPβ/ζ knockdown of DU145 and PC3 cells show that syndecan-3 
enhances epithelial-to-mesenchymal transition (EMT), which leads to increased migration of human 
prostate cancer cells and promotes cancer metastasis (Diamantopoulou et al, 2012). 
Alterations in syndecan expression are found in many different cancers (Fears and Woods, 
2006).  Syndecan-1 is over-expressed in head and neck squamous cell carcinoma (Inki et al, 1994). 
In contrast, decrease in syndecan-1 expression may be an early and poor prognostic factor in 
cervical carcinogenesis (Shinyo et al, 2004).  
Syndecans play an important role in pregnancy-related tumors. Decrease in expression of 
syndecan -1, -2 and -4 in the pathological tissues during gestational trophoblastic disease may lead 
to imbalance between syndecan and growth factors/cytokines and proteases/antiproteases 
(Subramanian et al, 1997) and therefore to trophoblast invasion. Decrease in immunostaining of 
these PGs links with increased severity of trophoblastic disease and could be used as a biomarker 
(Crescimanno et al, 1999).  
2.6.3. Syndecans in tissue injury 
Syndecans control both acute and late phases of tissue injury (Bartlett et al, 2007). 
Syndecan-4 expression is induced in response to several diseases or tissue injuries. In vascular 
injury syndecan-4 is an early response gene (Cizmeci-Smith et al, 1997). Its transcripts are induced 
rapidly, whereas syndecan-1 is expressed with some delay within a few days, and syndecan-2 and -
3 expression levels do not change (Cizmeci-Smith et al, 1997). Syndecan-4 plays an important role 
in skeletal muscle development and regeneration through activation of satellite cells and their 
proliferation. It has been shown by observation of myogenesis in adherent colonies and in 
regeneration experiments with barium chloride injection (Cornelison et al, 2004). All four 
syndecan mRNA transcripts are upregulated in brain cryo-injury model (Iseki et al, 2002). 
Syndecan-3 may function as a reservoir for HB-GAM and midkine in brain to promote axonal 
outgrowth in injured tissue. Syndecan-3 is highly expressed and widely distributed at spinal cord 
injury sites (Takeuchi et al, 2013).  
2.6.4. Syndecans in control of feeding behavior 
It has been postulated that alteration in syndecan-3 level in hypothalamic regions may be 
involved in regulation of feeding behavior (Reizes et al, 2001). Food deprivation increases 
syndecan-3 level at the cell surface which leads to decrease of melanocortin (α-MSH) activity via 
binding of syndecan-3 to agouti-related protein (AgRP) (Reizes et al, 2003). Finally, this increases 
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food intake. Other authors postulate the idea that syndecan-3 may control food intake independently 
of melanocortin-3/4 receptors (Creemers et al, 2006). It has been shown that syndecan-3 null 
(Sdc3
-/-
) mice show resistance to high-fat dietary obesity (Strader et al, 2004; Zheng et al, 2010). 
Interestingly, a strong positive correlation of obesity with three SNPs [T271I (rs2282440), D245N 
(rs4949184), and V150I (rs2491132)] of syndecan-3 was found in the Korean population. All three 
SNPs were located in the extracellular domain (Ha et al, 2003). 
 
2.7. Syndecan interactions 
Syndecans interact with a broad spectrum of ligands, like various heparin-binding growth 
factors, ECM proteins, cytokines, chemokines, enzymes, and with other transmembrane receptors 
(Fig. 6). Furthermore, interaction of a given syndecan with a ligand may also depend on tissue, but 
some growth factors interact with all four syndecans.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Syndecan functions in the cell. Syndecans interact with a various heparin-
binding growth factors, ECM proteins, cytokines, chemokines, enzymes, and with other 
transmembrane receptors where they act as a co-receptors. From Bishop et al, 2007 (with 
permission from Nature Publishing Group). 
 
24 
 
2.7.1. Growth factors 
There are quite a few growth factors which interact with syndecans, such as heparin-binding 
growth-associated molecule (HB-GAM) (Merenmies and Rauvala, 1990), basic fibroblast growth 
factor (bFGF, FGF2) (Selleck, 2006) and platelet-derived growth factor (PDGF) (Elfenbein and 
Simons, 2013).  
Basic fibroblast growth factor is a ligand for all syndecans and plays an important role in the 
regulation of cell proliferation, survival, differentiation and migration processes. FGF2 receptors 
can use syndecans as co-receptors (Selleck, 2006) where metalloproteinases may regulate FGF2 
response by syndecan-1 shedding. In addition to co-receptor function, syndecans may play role as a 
signaling receptor for FGF2 (Elfenbein et al, 2009). Furthermore, it has been shown that syndecan-
1 and FGF-2 but not FGFR-1 are accumulated by tubulin-dependent manner in nuclei. Such 
localization depends on syndecan-1 sequence RMKKK which acts as a nuclear localization signal 
(Zong et al, 2009). 
The last steps of HS chain biosynthesis are very important for syndecan functions. 
Modifications by epimerase and sulfotransferases define a sulfation pattern of GAGs (N-, 2-O-, 6-
O- and 3-O-) which plays an important role in binding of various growth factors. Sulfation level of 
syndecan GAGs may be different during different stages of development or in response to injury 
(Sasisekharan and Venkataraman, 2000; Gama et al, 2006). It has been shown that 2-O- and N-
sulfation is responsible for interaction of FGF2 with heparin while 6-O-sulfate groups are involved 
in interaction of FGF2/heparin complex with the FGF receptor (Guimond et al, 1993; Rusnati et 
al, 1994).  
In addition to acting as co-receptors, syndecans have signaling capability of their own. 
Signaling pathways of some growth factors go mainly through syndecans. Pleiotrophin (PTN), also 
called heparin-binding growth-associated molecule (HB-GAM), acts as a major ligand for 
syndecan-3 and is involved in neurite outgrowth (Merenmies and Rauvala, 1990; Raulo et al, 
1994; Kinnunen et al, 1996; Kinnunen et al, 1998) (Fig. 7). Midkine, another growth factor, that 
is homologous to HB-GAM with thrombospondin type I repeats, interacts mainly with syndecan-1 
(Mitsiadis et al, 1995). 
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Figure 7. HB-GAM signaling pathway. HB-GAM binds to syndecan-3 through the 
heparan sulfate chains (HS). The C1 region of the syndecan intracellular domain interacts 
with c-Src which leads to activation of its substrate cortactin. The C2 region binds the PDZ 
domain of CASK and activates the actin-binding protein 4.1. CASK, cortactin and protein 
4.1 are involved in formation of the cytoskeleton scaffold and promoting cell migration. 
(based on Raulo et al., 1994, Kinnunen et al, 1998 and Cohen et al, 1998). 
 
Both heparinase I treatment and experiments with neutralizing antibodies indicate that 
syndecan-3 interacts with Indian hedgehog (IHH) via the IHH heparin-binding domain, and may be 
involved in regulation of chondrocyte differentiation, proliferation and maturation (Shimo et al, 
2004; Pacifici et al, 2005). Syndecans also play a role in WNT signaling pathway. Syndecan-1 acts 
as a co-receptor for the Wnt-1-receptor (Alexander et al, 2000) and syndecan-4 from Xenopus 
laevis embryos (xSyn4) is involved in non-canonical Wnt pathway, where it interacts with Wnt 
receptor Frizzled7 (xFz7) and its signal transducer Dishevelled (xDsh) (Muñoz et al, 2006). 
Syndecans -1 and -3 may regulate through their HS chains the action of two neuropeptides 
produced in the brain: ASIP (agouti signaling protein) and AgRP (agouti related protein) (Reizes et 
al, 2001). These interactions lead to increased food intake via decrease of melanocortin (α-MSH) 
activity (Reizes et al, 2003). 
2.7.2. Cytokines 
Syndecans are involved in signaling pathways of some cytokines, such as transforming 
growth factor beta 1 (TGF-β1) (Go et al, 2010) and granulocyte-macrophage colony-stimulating 
factor (GM-CSF) (Modrowski et al, 2010). Interestingly, tumor necrosis factor (TNF) suppresses 
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expression of syndecan-1 (Kainulainen et al, 1996) but induces syndecan-4 expression (Zhang et 
al, 1996). 
Syndecans may interact with some chemokines and thus regulate inflammation processes. 
Syndecan-4 forms a complex with C-X-C chemokine receptor type 4 (CXCR4) (Hamon et al, 
2004) or CXCR7 (Schanz et al, 2011) receptors and directly with their ligand, C-X-C motif 
chemokine ligand 12 (CXCL12), also called stromal-derived-factor-1 (SDF-1). This complex 
formation is GAG-dependent mainly for syndecan-4/CXCL12 interaction (Schanz et al, 2011). 
Pretreatment of cells with heparinase I and III and chondroitinase ABC shows that formation of 
syndecan-4/CXCR4 complex is based on protein–protein interactions (Hamon et al, 2004; 
Charnaux et al, 2005). Migration and invasion experiments with Huh7 cells show that syndecan-1 
and -4 bind C-C chemokine ligand 5 (CCL5), also called RANTES (regulated on activation, normal 
T cell expressed and secreted), and play an important role in cell migration and invasion (Charni et 
al, 2009). 
2.7.3. Extracellular Matrix proteins 
Syndecans interact with many glycoproteins of the ECM. Interactions with fibronectin are 
involved in cell migration, differentiation and adhesion, and implicated in wound healing. 
Syndecan-4 binds through GAG chains heparin-binding fragment of fibronectin (HepII) and may 
control formation of focal adhesion processes (Woods et al, 2000). In turn, syndecan-1 regulates 
fibronectin fibril assembly via integrin activation (Stepp et al, 2010). Other abundant glycoproteins 
that interact with syndecan are vitronectin (Longley et al, 1999) and tenascin-C (Tkachenko et al, 
2000). Tenascin-C binds to fibronectin and by competing with syndecan-4 prevents cell adhesion 
(Huang et al, 2000). In addition, tenascin-C may interact directly with syndecan-3 (Koyama et al, 
1995) and -4 (Thesleff et al, 1995). 
The protein cores of syndecans interact with many enzymes which mainly regulate syndecan 
shedding: plasmin (Schmidt et al, 2005), thrombin (Subramanian et al, 1999), MMP-2, -3, -7, -9 
and membrane-type MMP (MT1-MMP) (Choi et al, 2012; Manon-Jensen et al, 2013). Although 
some enzymes may cleave syndecan protein core in the N-terminal part, the main cleavage sites are 
localized in the juxtamembrane region (Fig. 8). Many proteinases may cleave the core proteins at 
more than one site. 
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Figure 8. Cleavage sites of syndecan ectodomains. Known proteinase cleavage sites for 
syndecan -1 and -4- which involved in syndecan shedding. From Manon-Jensen et al, 2013 
(with permission from John Wiley & Sons, Inc.). 
 
Heparanase is another enzyme which is widely involved in regulation of syndecan functions. 
Cleavage of HS chains of syndecan-1 by endogenous heparanase (HPSE) is required for activation 
of lacritin which promotes epithelial proliferation (Ma et al, 2006). In addition, heparanase 
regulates signaling of vascular endothelial growth factor (VEGF) and hepatocyte growth factor 
(HGF) by releasing growth factors from syndecan-1 (Yang al, 20007; Ramani et al, 2013). 
Syndecan-1 and glypican-1 regulate anosmin-1 (KAL-1) signaling. This protein is involved 
in early development of optic tract and is defective in human Kallmann syndrome (Hudson et al, 
2006). 
Syndecans interact also with the major proteins of basal lamina – laminins. These 
interactions were initially found for syndecan-1 and later for syndecan-4. It was shown that 
alterations in the number of highly sulfated domains of HS chains in different cell types may affect 
interaction between laminins and syndecan-1 (Hoffman et al, 1998). In addition, the regulation 
may be affected by overlap of syndecan-1 and -4 binding sites in the laminin globular (G) domain 
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(Carulli et al, 2012). In some cases such interaction is strongly required for cell migration (Bachy 
et al, 2008).  
2.7.4. Cell adhesion molecules (CAMs) 
Syndecan-1 interacts and activates αvβ3 and αvβ5 integrins via insulin-like growth factor-1 
receptor (IGF1R) by IGF1-independent manner (Beauvais and Rapraeger, 2010). Such kind of 
complex is strongly required for VEGF (vascular endothelial growth factor) signaling and for 
endothelial cell dissemination during angiogenesis (Rapraeger et al, 2013). Activation of α5β1 
integrin which is involved in focal adhesion formation and cell migration occurs through binding to 
syndecan-4 and leads to increased activity of PKCα (Mostafavi-Pour et al, 2003; Bass and 
Humphries, 2002).  
Selectins are involved in interaction with syndecan-1, -2 and -4, which regulate leukocyte 
rolling. It appears that only E-selectin, but not P- or L-selectin, is responsible for such interactions 
(Götte et al, 2002; Götte, 2003b). Another step of leukocyte homing, transendothelial and 
transepithelial stages of leukocyte migration, is regulated by syndecan-E-cadherin interactions 
(Contreras et al, 2001) 
2.7.5. Interactions with other receptors 
In addition to cell adhesion molecules, syndecans interact with a few other receptors on the 
cell surface. The EphB2 receptor may form a complex with syndecan-2 to regulate dendritic spine 
formation in hippocampal neurons (Ethell et al, 2001). 
Syndecan in Drosophila may act as a ligand for leukocyte common antigen–related family 
receptor protein tyrosine phosphatase (LAR-RPTP) which regulates axon guidance and growth cone 
migration in embryos and larvae (Fox and Zinn, 2005). 
FRET experiments show that in addition to presenting the HB-EGF ligand to EGFR, 
syndecan directly interacts with this receptor at the cell membrane and induces clustering in the 
base of the growing neurite (Hienola et al, 2009). 
2.7.6. Syndecan dimerization 
Receptor dimerization is a crucial biological mechanism for receptor activation and also 
plays a big role in signal transduction through syndecans (Choi et al, 2005; Kulesskiy et al, 2013). 
All three domains, ecto-, transmembrane and cytoplasmic, may participate in syndecan 
oligomerization. The main role belongs to the transmembrane domain. All syndecans have highly 
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conserved sequences in this part of the protein core. They all contain a GXXXG motif, which is the 
most common sequence that may mediate helix-helix association with high affinity (Lemmon et al, 
1994; Russ and Engelman, 2000). In syndecans -2, -3 and -4 the transmembrane domains are 
sufficient for inducing dimerization (Choi et al, 2005). 
The last four amino acids (ERKE) in the juxtamembrane region form the most important for 
oligomerization motif in ectodomain of syndecan-3. The main role in complex formation is played 
by the lysine residue (Asundi and Carey, 1995). Other syndecans also have a similar motif, DRKE 
(syndecan-1), KRTE (syndecan-2) and ERTE (syndecan-4) but deletion of these motifs does not 
decrease SDS-resistant dimer formation (Choi et al, 2005). Some other part of the syndecan-3 
ectodomain may also be involved in protein-protein interactions to form dimers or oligomers. 
Molecular modeling predicts stalk-like configuration between the amino acids 124 to 196 in the 
ectodomain of syndecan-3. The sequence contains β-strand segments which cannot exist in isolation 
and these strands may form parallel β-sheets which may lead to dimer formation (Kirsch et al, 
2002). 
The cytoplasmic domain is a less important part of the syndecan protein core for 
oligomerization. Only the variable region may be somehow involved in complex formation. 
Synthetic peptides of syndecan-4 may form two parallel strands and twist twice in the V region, 
which leads to formation of a symmetric dimer (Shin et al, 2001). 
 
2.8. Resonance energy transfer techniques as a tools to study protein-protein interactions  
Receptor dimerization is a crucial biological mechanism for receptor activation and 
regulation of signal transduction. Activation of many receptor tyrosine kinases and other receptors 
that contain a single transmembrane domain occurs through dimerization in response to ligand 
binding (Heldin, 1995; Schlessinger, 2002; Lemmon and Schlessinger, 1994; Weiss and 
Schlessinger, 1998). Syndecans can form SDS-resistant dimers and for syndecan 2 and 4 
dimerization is implicated in receptor activation (Choi et al, 2005). For syndecan-3, it was 
proposed that dimerization is involved in various signaling processes (Asundi and Carey, 1995; 
Carey, 1994). However, dimerization and signal transduction upon ligand binding has not been 
directly demonstrated.  
Several cell biological and biochemical approaches can be used to  identify potential 
protein-protein interactions, such as co-immunoprecipitation, size exclusion chromatography, 
covalent cross-linking experiments, phage display or yeast two-hybrid assays (Lax et al, 1991). Just 
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a few of these approaches have been previously used for studying syndecan-3 dimerization. 
Unfortunately, these studies were mainly done with only short peptides (Dews and Mackenzie, 
2007) fused to glutathione s-transferase (GST) (Choi et al, 2005), with maltose-binding protein 
(MBP) (Asundi and Carey, 1995) or by using synthetic peptides. These methods are not suitable to 
study interactions in living cells. 
2.8.1. Fluorescence resonance energy transfer (FRET) 
Green fluorescent protein (GFP) isolated from jellyfish Aequorea victoria and its mutant 
forms, enhanced GFP, blue, cyan and yellow fluorescent protein (EGFP, BFP, CFP and YFP) as 
well as some fluorescent proteins from many other polyps are widely used in creation of genetically 
encoded fluorescent labels for fusion proteins. Many of these colour variants can be easily separated 
in fluorescence microscopy, allowing them to be used in combination. Fluorescence microscopy 
techniques like fluorescence recovery after photobleaching (FRAP) (Sprague et al, 2005; Shimi et 
al, 2004), fluorescence loss in photobleaching (FLIP) (Chen et al, 2003; Ishikawa-Ankerhold et 
al, 2012), fluorescence resonance energy transfer (FRET) and total internal reflection fluorescence 
microscopy (TIRF) (Riven et al, 2012) provide a unique opportunity to study the behavior of two 
or more independent tagged proteins in their natural environment in the living cell.  
Förster or fluorescence resonance energy transfer (FRET) adapted to different colour 
fluorescent protein tags (e.g. CFP and YFP) (Sorkin et al, 2000) offers a powerful method to study 
the complex behavior and spatial interaction of key regulatory proteins in a living cell. FRET 
measures a distance-dependent (1-10 nM) interaction between the electronic excited states of two 
dye molecules in which excitation is transferred from a donor molecule to an acceptor molecule 
without emission of a photon. It is an elegant experimental tool to examine the spatial relationship 
between two proteins in live cells. FRET can be used in many different ways to show 
intramolecular conformational changes (Ottolia et al, 2004; Dong et al, 2004) or for visualization 
of protein-protein interactions (Dinger et al, 2003; Sorkin, 2001; Erickson, 2001). There are 
various important factors which may affect  resonance energy transfer: overlap of donor and 
acceptor spectrums and distance between fluorophores and their angular orientation. 
There are a few techniques for FRET measurements. The first one is fluorescence lifetime 
imaging microscopy (FLIM) which is based on fluorescent lifetime measurements of donor 
fluorophore. The main disadvantage of this method is that complex equipment is needed to measure 
such fast process like return of the donor molecule from excited to ground state (Chen et al, 2004). 
The second very common way of measuring and quantification of FRET is acceptor 
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photobleaching (Karpova et al, 2003; Daelemans et al, 2004). This method is based on 
measurement of fluorescent intensity of donor before and after acceptor photobleaching. The main 
advantage of this technique is a very simple and fast quantification of FRET efficiency. Usually this 
method requires no spectral correction. Unfortunately, acceptor photobleaching is destructive for 
acceptor fluorophore and can be applied only once for each cell. That restriction does not allow 
studying dynamic processes in live cells. The third method of FRET measurement is sensitized 
emission (Ottolia et al, 2004; Sorkin et al, 2000) based on capturing of three images in donor, 
acceptor and FRET channels followed by spectral cross-talk correction and normalization of FRET 
images (Youvan et al., 1997; Gordon et al., 1998; Xia and Liu, 2001; Zal and Gascoigne, 2004). 
Nowadays there are a few correction algorithms which compete with each other (Xia and Liu, 
2001). Sensitized emission can be used to study rapid dynamic processes like receptor dimerization. 
I have used fluorescence resonance energy transfer microscopy with sensitized emission technique 
for dynamic analysis of syndecan-3 oligomerization upon binding of its ligand HB-GAM and to 
study interaction of syndecan-3 with other receptors. 
2.8.2. Bioluminescence resonance energy transfer (BRET) 
Another technique that was applied to study important amino acid residues in 
transmembrane and juxtamembrane parts of syndecan-3 is bioluminescence resonance energy 
transfer (BRET). Although aequorin and GFP were discovered by Osamu Shimomura in 1961 and 
the mechanism of energy transfer from aequorin to GFP was already shown in 1974, 
bioluminescence resonance energy transfer was first applied in 1999 to study interaction of 
circadian clock proteins (Xu et al., 1997). BRET is based on a similar principle as FRET but it 
utilizes bioluminescence rather than fluorescence, and because of a more robust signal it provides 
possibilities to simultaneously analyze multiple conditions, allowing simple and efficient screening. 
Currently there are few generations of BRET system which differ by acceptor fluorescent protein 
(wtGFP, GFP2, YFP), donor photoprotein (aequorin, Renilla luciferase and Gaussia luciferases and 
their mutant variants (RLuc8)) and by luciferase substrates (coelenterazine-h, DeepBlueC 
coelenterazine-400a (DBC)) (De et al., 2009). BRET2 method (acceptor GFP2 and DBC substrate) 
has a better separated donor and acceptor emission peaks than classical BRET. This gives 
opportunity to use BRET2 in screening assays with high signal to noise ratios (Pfleger and Eidne, 
2006; Bacart et al., 2008). BRET2 has been also used in the current study to explore different 
syndecan-3 ligands and their influence on the receptor oligomerization. 
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3. AIMS OF THE STUDY 
 
The aim of this study was to explore syndecan-3 interactions at the surface of live cells 
using FRET and BRET techniques. The specific aims of this work were: 
 
1. To study syndecan-3 dimerization at the cell surface upon binding of different ligands. 
2. To analyze in live cells the effect of site-directed mutagenesis on amino acid residues 
required for dimerization of syndecan-3. 
3. To study new protein-protein interactions of the syndecan-3 receptor.  
4. To identify a novel receptor for HB-GAM. 
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4. 4MATERIALS AND METHODS 
4.1. Cell cultures and transfection 
4.1.1. Eukaryotic cell lines 
The following cell lines from the American Type Culture Collection (ATCC) were used in 
this project: Human Embryonic Kidney 293 (HEK293), Rattus norvegicus brain glioma (C6), 
Chinese hamster ovary (CHO) cells and their deficient in xylosyltransferase mutant pgsA-745 
(deficiency in GAG synthesis). Mouse hippocampal primary neurons were isolated from E17-18 
embryos and cultured in B-27 (Invitrogen) and N-2 (Invitrogen) supplemented Neurobasal medium 
(Gibco). 
4.1.2. Transfection 
All cell lines were transfected by lipofection with FuGENE6 (Promega), EscortV (Sigma-
Aldrich), JetPei (Polyplus-Transfection) or Lipofectamine2000 (Lifetechnologies) reagents using 
standard protocols. Primary cells were electroporated with Amaxa Nucleofector Device (Lonza) and 
Rat Neuron Nucleofector Kit (Lonza) using O-03 or G-13 protocols. 
4.2. Molecular cloning and protein expression 
4.2.1. E. coli strains  
Standard techniques for cloning and amplification of DNA were applied. The following 
Escherichia coli strains were used for cloning of FRET and BRET constructs: XL1-Blue 
(Stratagene), SURE (Agilent Technologies), DH5a (Invitrogen), TOP10 (Invitrogen) GM2929 
(CGSC), and BJ5183 (Andres Merits, Tartu). Protein expression was done in BL21(DE3) 
(Novagen) and ER2508 (NEB). 
4.2.2. Vectors 
Cloning and expression vectors used in this work were: pEYFP-C1 (Clontech), pECFP-C1 
(Clontech), pEGFP-N1 (Clontech), pCAG-DsRed (AddGene), signal-pIg+ (R&D Systems), 
pcDNA6/V5-HisA (Invitrogen), pET29a+ (Novagen), pMAL-C2E (AddGene), pRL-TK (Promega), 
pGFP2-Rluc(h) (PerkinElmer), pCMV6-XL4 (OriGene), pSMART2IF (Clontech), pIRES-GFP 
(Clontech), pSV3-neo (ATCC), pASK-IBA5 (IBA), pGEX-2T (GE Lifesciences) and pGEM-T 
(Promega). Two viral systems for gene delivery were used in the project: lentiviral (TronoLab) 
(pWPT-NS, pMD2.G, pMDLg/pRRE, pRSV-rev) and adenoviral (pAdEasy1, pAdEasy2, 
pAdShuttle-CMV, pAdTrack-CMV) vectors.  
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4.2.3. cDNA library construction 
To find new receptors for the main syndecan-3 ligand HB-GAM, a cDNA expression library 
was constructed based on total RNA from E10-E12 mouse embryo brain and SMART cDNA 
Library Construction Kit (Clontech) with some modifications. The expression library was cloned in 
different vectors: pSMART2IF, pEYFP-C1, pCMV6-XL4, pWPT and pIRES. 
4.2.4. Site-directed mutagenesis 
Site-directed mutagenesis of syndecan-3 was done by PCR following by DNA product 
cleavage using the restriction enzyme DpnI (Fisher and Pei, 1997) with the primers: 
K383A 
CAGAAGAGCATACTAGAGCGGGCGGAGGTGCTCGTAGCTGTGAT 
ATCACAGCTACGAGCACCTCCGCCCGCTCTAGTATGCTCTTCTG 
G392L/G396L 
TAGCTGTGATCGTACTTGGCGTGGTGCTCGCCCTCTTCGCTGCCTT 
AAGGCAGCGAAGAGGGCGAGCACCACGCCAAGTACGATCACAGCTA 
 
 
4.3. Fluorescent microscopy 
The following fluorescent protein tags were used for FRET and BRET experiments: YFP, 
CFP, GFP, DsRed, GFP2, Venus cp173 (YC3.60) and Phluorin. Images were recorded in live 
transfected cells in CellR (Olympus) platform. The images were acquired in binning 2 × 2 modes to 
increase the signal-to-noise ratio. To avoid bleaching 300 - 500 ms integration times were used. 
Imaging was performed 24 hours after transfection with fluorescent constructs in serum-free 
medium at the temperature 22˚C - 24˚C using the temperature control incubator (Solent Scientific) 
to reduce the movements of cellular organelles. Images were collected with a CCD camera 
(Hamamatsu). 
4.3.1. FRET imaging, normalization and analysis 
Acceptor photobleaching and sensitized emission techniques of FRET were used in the 
current work. Both of them gave similar results, and to track syndecan-3 dynamic processes 
sensitized emission was selected. It is based on capturing of three images in donor, acceptor and 
FRET channels followed by spectral cross-talk correction and normalization of FRET images. 
FRET signal was quantified with three filter sets (Chroma): CFP channel (excitation 436/20, 
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dichroic longpass 455, emission 480/40), FRET channel (EX436/20, DCLP 455, EM535/30) and 
YFP channel (EX500/20, DCLP515, EM535/30). The background correction was done before all 
FRET calculations. FRET images were corrected for crosstalk between CFP and YFP channels with 
the following formula: 
Fc = FRET – a*CFP – b*YFP 
Correction factors were determined each time for a new type of cells and new medium from 
separately expressed donor or acceptor cells: for each fluorophore, the emission from the FRET 
channel was divided by the emission measured with either the CFP or YFP channels. 
Since FRET imaging analysis needs many spectral crosstalk corrections and may be quite 
difficult in interpretation, the first EGFR/Sdc-3 FRET experiments and the first BRET experiments 
were run with cells that were pre-transfected with constructs of which I was unaware. Such blinded 
experiments were done to ensure that all control parameters were calculated correctly and were not 
prone to subjective bias in interpretation of protein-protein interactions. 
4.3.2. TIRF 
TIRF (Total internal reflection fluorescence) microscopy was used to check proper 
membrane localization (I: Fig. S2).  The CellR (Olympus) imaging system was equipped with 488 
nm and 532 nm Diode-pumped solid-state (DPSS) lasers (Melles Griot) for TIRF imaging of GFP 
(CFP, YFP) and DsRed fluorophores. 
 
4.4. BRET assay 
Bioluminescence resonance energy transfer was used to compare dimerization of syndecan-
3 upon binding of different ligands and to visualize potentially important amino acid residues. I 
used BRET2 method with a final concentration of DBC substrate 5 µM. Cells were transferred to 
pre-coated white 96-well OptiPlate microplates (PerkinElmer) 24-48 h after transfection. 
DeepBlueC coelenterazine substrate was added by dispenser module to each well followed by 
measurements of signal in 410/80 nm and 515/30 nm channels in VICTOR
3
 Multilabel Plate Reader 
(PerkinElmer). Due to low level of luminescence and to reduce non-specifically increasing BRET2 
signal the total amount of cells was at least 50,000 cells per well (Hamdan et al., 2009). After 
background subtraction, BRET2 signal was calculated as a ratio of emission at 515 nm to emission 
at 410 nm (minus background). 
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4.5. In Search of  new interactions for HB-GAM and syndecan-3  
4.5.1. Receptor Affinity Probe (RAP) assay 
CHO and pgsA-745 (deficiency in GAG synthesis) cell lines were transfected by DNA from 
Gene Expression Panel cDNAs (OriGene). HB-GAM-PLAP (Placental alkaline phosphatase) fusion 
protein was incubated on top of the cells on ice for 2 h followed by PFA (4%) fixation and alkaline 
phosphatase staining. After initial screening of a whole Gene Expression Panel cDNAs, a few wells 
were selected for further experiments.  
4.5.2. Pull-down assay 
Hippocampal primary neurons were pre-cultured with 1 mM xyloside (Sigma-Aldrich) or 
0.1 mM selenite (Sigma-Aldrich) to prevent glycosylation of PGs. After 2 h incubation with 
magnetic beads covalently linked to different ligands, a cross-linking reagent DTSSP (Pierce) in 
2mM concentration was added. After lysis by RIPA buffer with 60 mM octyl-beta-D-
glucopyranoside (Piercenet) or 50-100 mM n-Dodecyl β-D-maltoside (Sigma-Aldrich), a 
transmembrane fraction was collected by magnets, and analysed by mass spectrometry. In addition 
a pull-down assay was done with the CHO and pgsA-745 cells which had been transfected by the 
home-made cDNA expression library (E10-E12 mouse embryo brain). Positive hits from 
cDNAs Gene Expression Panel previously found by RAP assay were tested as well in pull-down 
assay. 
4.5.3. Mass spectrometry 
Samples after pull-down assay were analysed by liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) via Mascot database search.  After subtraction of hits which were 
common with BSA controls, a list of potential interaction proteins was sorted based on Mascot 
score. 
4.5.4.  Analysis of neurite outgrowth 
Hit validation was done in neurite outgrowth assay using hippocampal primary neurons with 
siRNA knockdown or by using Phospholipase C (PLC) enzyme P-8804-5UN (Sigma-Aldrich). 
Primary neurons were collected from E18 mouse embryos and seeded on plates pre-coated by 
different ligands. Neurite outgrowth was defined by counting of processes more than twice the 
diameter of the cell soma. Due to electroporation, a large number of cells were dead after 24 h and 
in some cases it was quite difficult to distinguish the condition of the cells.  For a more accurate 
quantification, I calculated the total number of processes to a final number of cells (alive and dead). 
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4.5.5. Statistical analysis. 
Statistical analysis was done in StatView. T-test for treated (PLC or siRNA) cells vs "no 
treatment" group. 8 -16 wells were used for each condition. Four randomly chosen microscope 
fields in each well were selected. 
 
4.6. Quality control of cellular localization of fluorescent constructs 
It has been shown previously that labeling of some proteins with different fluorescent tags 
may lead to wrong intracellular localizations of fusion proteins (Hanson and Ziegler, 2004). To 
control localization of FRET and BRET constructs all fluorescently labeled syndecan-3 proteins 
were stained by different antibodies: syndecan sc-9496 (SantaCruz), GFP sc-8334 (SantaCruz). In 
addition, TIRF (Total internal reflection fluorescence) microscopy was used to confirm membrane 
localization. 
Glycosylation of all syndecan-3 constructs was examined by western blotting before and 
after treatment with heparinase I and III (H2519, H8891, Sigma-Aldrich) and by fluorescent 
colocalization experiments with HB-GAM labeled by Cy3. Labeling of HB-GAM was done on 
heparin column to protect amino acid residues important for heparin binding. 
In addition, a fluorescently labeled short transmembrane sequence of PRR7 (proline rich 7 
protein from postsynaptic densities) was used as a negative control in some FRET experiments. 
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5. RESULTS AND DISCUSSION 
5.1. Syndecan-3 oligomerization (I, II) 
In this work I have studied oligomerization of syndecan-3 upon binding of its ligands. 
Receptor oligomerization/dimerization is a rapid dynamic process which is crucial for receptor 
activation and regulation of signal transduction. It was proposed that dimerization of syndecan is 
involved in various signaling processes (Asundi and Carey, 1995; Carey, 1994). In addition, some 
experiments have shown that syndecans can form SDS-resistant dimers (Choi et al, 2005). 
Unfortunately, all these studies were done with synthetic peptides or with short peptides (Dews and 
Mackenzie, 2007) fused to GST (Choi et al, 2005) or to MBP (Asundi and Carey, 1995) (Table 
2). The second disadvantage is due to the methods used for protein-protein interaction studies. Size 
exclusion chromatography, co-immunoprecipitation and covalent cross-linking experiments 
combined with SDS−PAGE are not able to provide information about dynamic processes on the 
surface of living cells. In addition, for those experiments where full-length core proteins were used, 
controls for proper cellular localization are very difficult. Overexpression of exogenous proteins 
may lead to incorrect localization or to accumulation in endoplasmic reticulum causing false-
positive results. 
Table 2. Methods used to study homo- or heterodimerization of syndecans 
Syndecan family receptors Detection methods References 
Syndecan-1 Western blot with Syndecan-1 antibodies Carey DJ et al, 1994 
Syndecan-2 SDS−PAGE of  GST-syndecan-2 fusion protein Choi S et al, 2005 
Syndecan-3 
 
 
 
 
Gel filtration chromatography of fusion 
proteins expressed in E.coli (MBP-N-Syndecan) 
 
SDS−PAGE of cross-linked  proteins 
overexpressed in HEK 293T cells 
Asundi VK and Carey DJ, 1995 
 
 
Kirsch T et al, 2002 
 
Syndecan-4 
 
Gel filtration chromatography and SDS−PAGE 
of core protein and synthetic peptides 
Oh et al, 1997 
 
Homotypic and 
heterotypic interactions 
TOXCAT Assay and SDS−PAGE of short 
transmembrane peptides (20-21 a.a.) 
Dews IC and MacKenzie KR, 2007 
 
39 
 
I have used fluorescence resonance energy transfer microscopy with sensitized emission 
technique (Fig. 9) for dynamic analysis of syndecan-3 oligomerization upon binding of its ligand 
HB-GAM and to study interaction of syndecan-3 with other receptors. Although expression of 
fluorescent fusion proteins provides good information on spatial and temporal protein distribution 
which correlates with immunofluorescence (Stadler et al, 2013), labeling of some proteins with 
different fluorescent tags may lead to wrong intracellular localizations of the fusion proteins 
(Hanson and Ziegler, 2004); to avoid such false positive results, for all fluorescently labeled 
syndecan-3 proteins membrane localization was confirmed by TIRF microscopy (I: Fig. S2b). 
Furthermore, accumulation of the FRET signal at the contacts of HB-GAM-coated beads 
with transfected cells (I: Fig. 2a) provides evidence of cell surface localization of glycosylated 
fluorescent syndecan-3 since HB-GAM binds the syndecan through its heparan sulfate chains 
(Raulo et al., 1994). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Principle of syndecan-3 dimerization studies by FRET microscopy. FRET 
measures a distance-dependent (1-10 nM) interaction between the electronic excited states 
of CFP and YFP. Upon HB-GAM (or other ligands) binding dimerization of syndecan-3 
may be registered by measurement of YFP emission (529 nm) after CFP excitation (439 
nm). 
 
5.1.1. Ligand-induced dimerization of syndecan-3 
The HEK293T cells that were co-expressing full-length syndecan-3 fused to CFP or YFP 
were used. When the cells were seeded on HB-GAM-coated surface (I: Fig. 1b) they show after 2-4 
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h incubation clearly higher FRET signal than controls seeded on BSA-coated surface (I: Fig. 1a). 
Interestingly, cells on BSA pre-coated surface showed some “basal” FRET signal (I: Fig. 1a). One 
of the explanations could be ligand-independent dimerization which has been observed for some 
other receptors (Yu et al, 2002). Even the cells with a lower expression (low intensity of 
fluorescence) show “basal” dimerization on BSA-surface. It suggests that overexpression of 
syndecan-3 constructs does not interfere with receptor dimerization. Increase of FRET signal upon 
addition of soluble HB-GAM indicated that syndecan-3 dimerization may also occur on the apical 
membrane (I: Fig. 1d). For negative control, cells were cotransfected with pECFP and pEYFP 
vectors. Positive control cells expressed pCFP-YFP plasmid with 23 amino acid linker. 
Unfortunately, it is very difficult to measure FRET signal in freshly attached cells since 
during the first minutes of receptor activation they are not yet properly attached to pre-coated 
surface. Floating cells start to adhere at different time points and it is quite hard to define a moment 
when certain cells initially attached to surface.  For more accurate detection of initial dimerization 
steps I used 2-week old primary cultures of rat hippocampal neurons (E17-18) which express FRET 
constructs. To prove that the increase in FRET signal is ligand-dependent, dimerization was 
induced by HB-GAM coated beads. The most intensive dimerization occurred in places where the 
beads contacted hippocampal neurons (I: Fig. 2a). In general, the FRET signal increased rapidly 
within 10 min and then slowly decreased within the next 2 hours. In addition, kinetic measurements 
were done by BRET. The highest signal was observed at 15 min, after which the signal gradually 
decreased (I: Fig. 3b). Such 5 minutes difference in HB-GAM induced syndecan-3 dimerization 
between FRET and BRET techniques can be explained by different conditions. BRET 
measurements were done with freshly added cells while FRET images were taken for well-attached 
cells where initial contact with HB-GAM beads can be recorded precisely and easily. Such kinetic 
range of the observed dimerization, peaking within 10-15 minutes, fits very well with the formation 
of the kinase signaling complex (20 min) on the syndecan-3 cytoplasmic tail after HB-GAM 
stimulation. This was previously reported by our group for c-Src and cortactin phosphorylation after 
culturing of syndecan-3 transfected N18 cells on the HB-GAM-coated matrix (Kinnunen et al, 
1998). This data also corresponds well to syndecan - actin colocalization results. Syndecan-3 and 
actin clearly showed colocalization within the first 30 minutes on HB-GAM (I: Fig. 4a) pre-coated 
surface. After 4 h, colocalization was mainly visible in cellular processes (I: Fig. 4b). 
In addition to mutagenesis studies (described below), BRET assay was also used to compare 
dimerization rate upon induction by different ligands. The BRET assay is widely used for studying 
ligand-induced conformational changes and/or dimerization of receptors as well as for searching 
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new ligands and/or drugs.  Another well-known syndecan-3 ligand bFGF (FGF-2) (Chernousov 
and Carey, 1993) shows a lower efficiency in dimerization compared to HB-GAM (I: Fig. 3a). 
It has been shown that laminin is involved in interactions with syndecan-1 and -4. (Hoffman 
et al, 1998; Carulli et al, 2012; Bachy et al, 2008) and in some cases such interaction is strongly 
required for cell migration. BRET experiments with laminin substrate do not show any increase in 
dimerization level of syndecan-3 (I: Fig. 3a). This finding confirms the results previously reported 
by our group that syndecan-3 is not important for laminin-induced neurite outgrowth (Kinnunen et 
al, 1996). 
5.1.2. Amino acids important for dimerization 
In addition, the possible role of syndecan-3 cytoplasmic domain in dimerization was studied. 
Earlier, it had been shown in size exclusion chromatography experiments with syndecan-4 synthetic 
peptides that the cytoplasmic domain is involved in formation of the stable dimer. Nuclear magnetic 
resonance studies have proposed that two parallel strands twist twice in the variable region and may 
form a symmetric dimer (Shin et al, 2001). I created syndecan-3 FRET constructs with a 
cytoplasmic tail deletion. These new variants had a similar level of FRET signal (I: Fig. 1c) as the 
full-length syndecan-3 construct suggesting that the cytoplasmic domain of syndecan-3 is not 
required for dimerization. 
By computational modelling and in experiments with mutant glycophorin A peptides in 
SDS-PAGE a pattern of 7 amino acids (LIxxGxxxGxxxT) was found which promotes dimerization 
(Lemmon et al, 1994).  ToxR transcription activator (ToxR) assay demonstrated later the 
importance of glycine residues and the GXXXG sequence that appears as the most crucial and the 
canonical motif for transmembrane interaction (Brosig and Langosch, 1998). This motif is the 
most common sequence in transmembrane proteins that may mediate helix-helix association with 
high affinity (Russ and Engelman, 2000). All members of syndecan family receptor contain a 
GXXXG motif in their transmembrane domain, important for helix-helix association with high 
affinity (Russ and Engelman, 2000). In addition, Asundi and Carey (1995) proposed that the lysine 
residue in the juxtamembrane (ERKE) sequence has a major role in self-association of syndecans 
on the membrane. Unfortunately all existing studies on syndecan dimerization lack experiments 
with full-length protein. One article described cell spreading after transfection of full-length mutant 
syndecan-1 in Raji cells but a whole transmembrane domain was replaced with a poly-lysine 
sequence which makes interpretation of the results difficult (McQuade and Rapraeger, 2003). 
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To elucidate the role of proposed amino acid residues in dimerization processes for full-
length syndecan-3 on the surface of living cells I created mutant variants of receptor (K383A and 
G392L/ G396L) which were fused to GFP2 and Rluc reporter genes. Although FRET microscopy 
offers the opportunity to study the temporal and spatial interaction of the tagged proteins and could 
be used for quantification studies, for a high number of different conditions a BRET technique may 
fit better because of a more robust signal. I applied the BRET2 assay to test dimerization upon 
ligand induction. As well as FRET constructs all BRET fusion proteins (S3-wt-GFP2, S3-wt-Rluc; 
S3-K383A-GFP2; S3-K383A-Rluc; S3-G392L/G396L-GFP2 and S3-G392L/G396L-Rluc) were 
tested for proper membrane localization (I: Fig. S2b). In addition, western blotting after heparinase 
treatment  shows that all mutant fusion constructs have core proteins of the expected size and are 
expressed in cells at comparable levels (I: Fig. S2a). 
The most important factors which influence BRET (and FRET) efficiency are: Spectral 
overlap of donor and acceptor spectrums; distance between fluorophores and their angular 
orientation (dipole/dipole interaction). In my experiments BRET signal ratio around 0.2 was found 
for wild type syndecan-3 fusion proteins on HB-GAM pre-coated surface. There is always some 
basal level of BRET signal even in absence of acceptor due to spectral bleed-through of 
luminescence in GFP (acceptor) channel. In the absence of HB-GAM, wild type syndecan-3 
constructs show a similar level of BRET signal ratio with BSA, laminin and poly-lysine pre-coated 
substrates (I: Fig. 3a). For both mutant variants a reduction of BRET signal was observed upon 
HB-GAM ligand binding as compared to the wild-type receptor. The K383A mutant shows the 
most dramatic reduction (I: Fig. 3c). This suggests that the lysine residue in the ERKE 
juxtamembrane region plays the most crucial role for full-length syndecan-3dimerization. In 
contrast, the G392L/G396L mutant results show that the GXXXG canonical motif may be not so 
important for dimerization in some transmembrane receptors. Interestingly, for amyloid precursor 
protein (APP) it was shown that the GXXXG motif is not needed for full-length APP dimerization 
and that the sequence may be crucial only for α- and β- secretase cleavage of APP (Munter et al, 
1994). 
Two other proposed motifs which may also be important for syndecan dimerization are the 
variable region in the cytoplasmic domain and amino acids 124 to 196 in the ectodomain that has a 
stalk-like configuration. These motifs were found by NMR studies of synthetic peptides and by 
molecular modeling prediction respectively. It is quite hard to estimate their real impact on 
dimerization of full-length receptor in living cell, especially as shown above for the cytoplasmic 
domain of syndecan-3 that is not required for dimerization (I: Fig. 1c). 
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Receptor internalization may play an important role in regulation of signal transduction. It 
has been shown that dimerization of receptor triggers its internalization (Wang et al, 2013). Due to 
fact that the ERKE juxtamembrane region is located direct near MT1-MMP cleavage site (Asundi 
et al, 2013) it may be possible that shedding from this particular cleavage site regulates 
internalization of syndecan-3 receptor. The BRET substrate, DeepBlueC coelenterazine, is 
membrane permeable and potentially may show luminescence and subsequent BRET signal from 
intracellular compartments like endoplasmic reticulum and endocytic vesicles. On the contrary, all 
mutant variants of syndeacan-3 show to some extent dimerization on pre-coated HB-GAM (I: Fig. 
3c), which may indicate that the dimerization occurs at the plasma membrane but not in an 
intracellular compartment. 
 
5.2.GDNF as a new ligand for synecan-3 (I, II) 
Previously published data suggests that GDNF can interact with HSPGs on the cell surface 
or in the ECM and that HSs are required as co-receptors for GDNF signaling (Barnett et al, 2002; 
Sariola and Saarma, 2003). 
  
Figure 11. Syndecan-3 oligomerization upon GDNF binding. FRET signal of syndecan-3 
dimerization revealing on the plasma membrane of HEK293T cells after GDNF stimulation. 
FRET images are displayed in pseudocolors (red - high FRET, blue - low FRET). From (II: 
Fig. 2D) (with permission from Rockefeller University Press). 
 
In experiments with GFLs, Bespalov et al. (II) found that neurturin (NRTN), artemin 
(ARTN) and GDNF (but not persephin, PSPN) bind to the HS-carrying extracellular domain of 
syndecan-3 with high affinity at 10-50 nM range and that GDNF may induce neurite outgrowth 
using HSPG (Figs. 11 and 12) through the proto-oncogene c-Src activation. Chemical cross-linking 
followed by co-immunoprecipitation confirms a high specificity of such interaction. During 
development GDNF and NRTN have expression patterns similar to syndecan-3 (II). 
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To prove and visualize such interaction on the surface of living cells I used FRET imaging 
(II: Fig. 2d). The first signal appears on the cell membrane in 5 min after GDNF stimulation and 
gradually increases in next 40 min. As discussed above, the BRET method demonstrates a very high 
accuracy. All negative control proteins display a low level of BRET signal. Interestingly, GDNF 
induced almost the same level syndecan dimerization as HB-GAM (I: Fig. 3a). The present data 
indicates that in spite of a similar receptor interaction and formation of the kinase signaling 
complex (Kinnunen et al, 1998) with observed dimerization peak within 10-15 minutes (I: Fig. 2a 
and I: Fig. 3b), HB-GAM induced a faster syndecan-3 dimerization than GDNF (II: Fig. 2d). 
 
 
 
 
 
 
 
 
Figure 12. Molecular interaction of syndecan-3 with GDNF in the regulation of cell 
motility. Phosphatidylinositol-specific PLC treatment shows that GDNF family receptor α 
(GFR-α) is not required for GDNF-syndecan-3 binding and soluble or ECM bound GDNF 
may act as a ligand for neurite outgrowth and neuronal migration. In presence of the 
conventional receptor complex GFR-α-RET, syndecan-3 may play a role as a co-receptor to 
concentrate and present GDNF. GDNF-syndecan-3 interaction is suggested to enhance 
differentiation of cortical GABAergic neurons and their tangential migration. From II (with 
permission from Rockefeller University Press). 
 
5.3.  Syndecan-3 as a co-receptor for HB-EGF  (III) 
Cell migration is a fundamental process during development.  Neuronal migration brings 
cells from their sites of origin into appropriate spatial positions, for example to the developing 
neocortex. It has been shown that EGF stimulates migration and proliferation of immature 
progenitor cells (Fricker-Gates et al, 2000; Aguirre et al, 2005). We found by BrdU
+
 staining, 
that syndecan-3 deficient mice show no EGF-induced radial neuronal migration in brain slices (III: 
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Fig. 1a). We propose that heparin-binding EGF-like growth factor (HB-EGF) induces chemotactic 
migration of neuronal progenitors and both EGFR and syndecan-3 are required for the migration. 
Importance of such interactions was shown in two independent experiments with HB-EGF agarose 
beads placed on living brain slices (III: Fig. 5) and in the migration chamber assay (III: Fig. 6). 
HB-EGF binds to syndecan-3 and acts as a common ligand of EGFR and syndecans, and might 
therefore bring the receptors together at the plasma membrane (III: Fig. 8). To prove this idea I 
have run FRET experiments. FRET analysis showed clustering of syndecan-3 with EGFR at the 
plasma membrane of HEK293T cells plated on HB-GAM upon HB-EGF stimulation (III: Fig. 7d). 
Interestingly, HB-EGF-induced clustering was much weaker on laminin matrix (III: Fig. 7e). The 
interaction was especially prominent in the base of the growing cell process (III: Fig. 7g).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Molecular interactions of syndecan-3 with HB-EGF and EGF receptor in 
the regulation of cell motility. HB-GAM triggers c-Src phosphorylation. In syndecan-3 
knockout cells such activation not occurs. From (III: Fig. 9) (with permission from 
Rockefeller University Press). 
 
Based on these results we conclude that in addition to HB-GAM-induced cell motility, 
syndecan-3 interacts with EGFR and such interaction is required for EGFR-induced neuronal 
migration. Signaling triggered by both HB-GAM and HB-EGF may go through the c-Src kinase 
activation (Fig. 13). Interestingly, syndecan-3 knockout forebrain cells still display migration at 
high concentrations of HB-GAM which may indicate existence of another migration-associated 
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receptor for HB-GAM (see 5.4.). In addition, c-Src phosphorylation in syndecan-3 knockout 
forebrain cells is partially observed (III: Fig. 4). 
5.4.Glypican-2 as a new receptor for HB-GAM (unpublished data) 
Although HB-GAM (pleiotrophin) tissue expression profile is very similar to syndecan-3 
(genecards.org), their temporal expression patterns are slightly different.  Syndecan-3 is expressed 
mainly in neuronal and skeletal tissues. These proteoglycan transcripts may be found from early 
stage of embryonic development (mouse E1.5). In situ hybridization and immunohistochemistry 
showed that syndecan-3 displays high expression during the whole period of embryogenesis. After 
2 weeks of postnatal development, syndecan-3 shows a sharp reduction in staining intensity (Hsueh 
and Sheng, 1999). However, HB-GAM is first expressed on E11-E12 (in contrast to syndecan-3) 
(Rauvala et al, 1994), reaches a peak at the early postnatal stage (P14), and the expression level 
then decreases (Merenmies and Rauvala, 1990; Marchionini et al, 2007; CDT database). 
Another HB-GAM receptor, PTPRZ1 (Receptor-type tyrosine-protein phosphatase zeta, RPTP β/ζ, 
Phosphacan) is highly expressed at the postnatal stage, but its expression pattern does not cover all 
tissues which produce HB-GAM. These findings suggest that some other receptor may be involved 
in HB-GAM signaling. 
Figure 14. Receptor alkaline phosphatase (RAP) assay (receptor affinity probe)  
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For searching new HB-GAM receptors, I used Receptor Affinity Probe (RAP) assay with 
HB-GAM-PLAP (Placental alkaline phosphatase), where a cDNA expression library (OriGene) was 
screened (Fig. 14). RAP assay initially was done in CHO cells but due a high background, pgsA-
745 (deficiency in xylosyltransferase) cell line was used in this assay. Such deficiency in GAG 
synthesis was used to detect potential protein-protein interactions of HB-GAM. Initially I used 
micromanipulation system and patch clamp pipettes to collect cells for single-cell PCR. Although 
PCR of a few control genes from single cells was successful, such strategy failed. Unfortunately, 
even when I used “junk” DNA plasmid to reduce false-positive PCR products, each time bands 
corresponding to Mus musculus beta actin were mainly found. The same pair of primers was used 
for screening of cDNA library and due to high expression level of beta actin such contamination 
appears in each sample. RAP assay was only useful for initial screening of the cDNA library (96 
wells). After screening of a library plate, 11 wells were selected for further experiments. In addition 
to adult mouse brain OriGene library (MAB1001), I have constructed a home-made cDNA 
expression library based on E10-E12 mouse embryo brain, a stage when initial expression of HB-
GAM was observed (Rauvala et al, 1994), 
Interestingly, Receptor Affinity Probe (RAP) assay with HB-GAM-PLAP gives a number of 
cells which show different staining patterns. For a few cells an “actin” network pattern can be seen. 
In other cells some “dots-type” staining is observed. (Supplement figure 1). This may be due to 
different receptors responsible for such interactions, and further studies of some hits from mass 
spectrometry may reveal new receptors for HB-GAM. 
By pull-down assay with a cross-linking reagent (DTSSP) and magnetic beads covalently 
linked to HB-GAM followed by electrospray ionisation mass spectrometry, I was able to get a 
number of hits for further analysis. In addition, I have used hippocampal primary neurons (E17-18) 
and embryonic R1 stem cells. Specificity of the screening method is suggested by occurrence of a 
multiple hits to the same proteins in the different cell types. 
One of the most promising hits in mass spectrometry results is glypican-2. It was found in 
two independent samples (hippocampal primary neurons) (Supplement table 1) with one of the 
highest scores (8
th
 out of 355 hits).  Glypican- 2 is an HSPG which is linked to the plasma 
membrane by glycophosphatidylinositol linker (GPI anchor). To confirm specificity of HB-GAM - 
glypican-2 interaction I have run neurite outgrowth assays with hippocampal primary neurons with 
and without Phosphatidylinositol-Specific Phospholipase C (PI-PLC) treatment (Fig. 15). Decrease 
to less than 50% in the number of processes for all concentrations of ligand was observed for PI-
PLC treated cells which were cultured on pre-coated HB-GAM plates (0.1, 1 and 10 µg/ml).  
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Figure 15. Neurite outgrowth assay with hippocampal primary neurons after PLC 
treatment. Different pre-coated concentrations of HB-GAM ligand were tested (0.1, 1 and 
10 µg/ml). Four microscope fields were randomly selected for quantification. The total 
number of neurites (mean outgrowth) was counted. * p-value < 0.05, t-test vs "no treatment" 
group. 
 
Furthermore, glypican-2 knockdown by siRNA followed by neurite outgrowth experiment 
gives a similar result compared to the Phospholipase C treatment (Fig. 16).  Reduction of neurite 
outgrowth was observed for 10µg/ml and 1µg/ml coating concentrations of HB-GAM. At the 
lowest concentration of HB-GAM there was no difference observed since the cells after 
electroporation were stressed and probably such a low level of ligand is not enough. 
 
 
 
 
 
 
 
Figure 16. Neurite outgrowth assay with hippocampal primary neurons after 
knockdown by glypican-2 (GPC2) and a control (SCR) siRNA. Four randomly 
microscope fields were selected. The total number of neurites per cell was counted 
(normalized to cells number). * p-value < 0.05, t-test vs "no treatment" group. 
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Both of these independent experiments suggest that glypican-2 is involved in HB-GAM 
mediated neurite outgrowth.  It has been shown previously that midkine binds to glypican-2 
(Kurosawa et al, 2001) and to syndecan-1, -3 and -4. Although HB-GAM has 45% sequence 
identity with midkine and these proteins form a family of mitogenic and angiogenic heparin–
binding growth and differentiation factors, their functions are not identical (Zhang and Deuel, 
1999). It has been shown that glypican-2 is highly expressed in the developing nervous system, and 
it has been proposed that the function of this receptor is in ”motile behaviors of developing 
neurons“ (Stripp et al, 1994) but no ligand has yet been found which could prove it. There are few 
outcomes of such interaction: glypican-2 may be involved in regulation of HB-GAM signaling by 
competing with syndecan-3 for ligand binding, may play a role of a co-receptor just like syndecan 
in some cases or activate its own signal pathway. Glypican-2 is a quite poorly studied molecule. 
Except midkine there are no other confirmed interactions. HB-GAM thus appears as an interesting 
potential ligand for glypican-2 in the regulation of motile behavior of cells. 
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6. CONCLUSIONS AND FUTURE DIRECTIONS 
Interactions of syndecan-3 at the surface of live cells were studied for the first time using 
FRET and BRET techniques. The main conclusions of this study can be summarized as 
follows: 
1. Syndecan-3 displays ligand-dependent (HB-GAM, GDNF) dimerization at the surface of 
live cells. HB-GAM-induced clustering increased rapidly within 10 min and then slowly 
decreased within the next 2 hours.  
2. The amino acids K383 from ERKE juxtamembrane region and to a much lower extent 
G392 and G396 are important for the dimerization. The previously proposed important 
dimerization motifs for syndecans do not appear to be essential since the whole cytoplasmic 
domain is not required for dimerization. 
3. GDNF is a new type of ligand for syndecan-3. Soluble GDNF may induce neurite outgrowth 
and neuronal migration. GDNF-induced stimulation of syndecan-3 dimerization reaches a 
maximum in 40 min after induction. 
4. Syndecan-3 acts as a co-receptor for HB-EGF binding with EGFR and this interaction is 
required for EGFR-induced neuronal migration. HB-GAM matrix is required for enhancing 
the syndecan-3/EGFR clustering and stabilization. 
5. Glypican-2 is identified as a potentially new receptor of HB-GAM. Glypican-2 regulates 
HB-GAM mediated neurite outgrowth. 
 
The work presents the first study on ligand-induced oligomerization of a syndecan family 
receptor in living cells, which was achieved by using HB-GAM induced syndecan-3 receptor. It will 
be very interesting to study hetero-dimerization of syndecan family receptors by FRET technique. 
In addition, further studies of some hits from mass spectrometry may reveal new receptors for HB-
GAM. 
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9. SUPPLEMENTS 
Supplement table 1. Hits with highest scores (Mascot database) in mass spectrometry 
results from pull-down assay with HB-GAM and BSA magnetic beads from hippocampal 
neuronal cultures. Mascot utilizes probability based scoring.  
 
The first 20 highest scoring hits (out of 355) in two independent samples from hippocampal 
primary neurons (E17-18) found by pull-down assay with a cross-linking reagent (DTSSP) 
and magnetic beads covalently linked to HB-GAM (HBGAM_1 and HBGAM_2) and BSA. 
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Supplement figure 1. 
Different staining patterns of cells in RAP assay. PgsA-745 cells expressing cDNA 
library from adult mouse brain (OriGene) after staining in Receptor Affinity Probe assay 
with HB-GAM-PLAP. Number of cells shows different staining patterns (“actin” network 
pattern, “dots-type” staining). 
 
